Presented By

Presented By

Continuing Education

Join the RESPTREC family for lifelong learning opportunities and mentorship.


CCCEP: The Education, COPD and Asthma courses have been accredited by Canadian Council on Continuing Education in Pharmacy. Pharmacists have been involved in development of the curricula and review of the content.

The Canadian Council on Continuing Education in Pharmacy has confirmed accreditation as follows:

  • Education for Chronic Disease Management Course - 27.50 CEUs
  • COPD Management Course - 21.50 CEUs
  • Asthma Management Course - 17.50 CEUs

Resources: Download or order RESPTREC resources:

  • Asthma Medications Brochure
  • COPD Medications Brochure
  • Delivery Device Instructions
  • Delivery Device Mastery Sheets

Webinars: Webinars on the most recent research, position papers, guidelines, topics are presented by leading experts in the field quarterly. 15 sites across western Canada participate. For those graduates who are unable to join a live session can access the presentations on-line, following the Webinar. Questions are posted following viewing of the presentation and a continuing education certificate can be printed for your records.

Current News

For your convenience RESPTREC provides links to research articles, announcements, studies and other news updates which are posted daily onto the website. Reading these articles can be used towards recertification and continuing education.

Watch for upcoming opportunities!

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Sep 19, 2017

The use of pirfenidone in IPF patients was associated with lower risk of nonelective respiratory-related hospitalization than placebo (7% vs 12%) over the course of 1 year. The effect of pirfenidone on death after hospitalization is uncertain.

Asthma in the elderly and late-onset adult asthma
Sep 19, 2017

Elderly asthmatics are at a higher risk for morbidity and mortality from their asthma than younger patients. There are important age-related physiologic and immunologic changes that complicate the presentation, diagnosis, and management of asthma in the aged population. 

Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand
Sep 19, 2017

This position paper aims to highlight the current evidence for the treatment of IPF, with particular application to the Australian and New Zealand population

Spirometry training courses: Content, delivery and assessment
Sep 19, 2017

The primary outcome of spirometry training courses should be to enable participants to perform spirometry to international best practice, including testing of subjects, quality assurance and interpretation of results: Australian and New Zealand Society of Respiratory Science position statement 

Does limb partitioning and positioning affect acute cardiorespiratory responses during strength exercises in patients with COPD?
Sep 19, 2017

Double-arm elevation above shoulder level appears to be more challenging than other strength exercise variations. Partitioning exercises and limb position may reduce perceived exertion during training.

Lung function in relation to farm dwelling and farming activities in rural dwelling children
Sep 19, 2017

A stufy of the association between lung function and rural exposures found that differences in lung function were seen between children living on a farm and not living on a farm in rural areas and certain farming activities, specifically emptying grain bins, where lung function was generally better in…

Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD
Sep 19, 2017

In patients with stable COPD, LAMA were associated with a greater reduction in acute exacerbations and fewer adverse effects compared with LABA. There were no significant differences in trough FEV1, TDI and SGRQ scores.

Multidimensional assessment of severe asthma
Sep 19, 2017

The management of severe asthma is complex. Multidimensional assessment of specific traits has been proposed as an effective strategy to manage severe asthma, although it is supported by few prospective studies.

Reviewing the relationship between OSA and cognition
Sep 19, 2017

 A growing body of research in obstructive sleep apnoea reveals a relatively consistent pattern of deficits in cognition, particularly in attention, episodic memory, and executive function, which are partially remediated by treatment

Partitioning strength exercises as an alternative training modality for patients with COPD
Sep 19, 2017

Most patients with COPD experience high levels of dyspnoea during exercise training. Partitioned exercises enable patients with COPD to maintain the same metabolic and functional demands on the targeted muscle, while the overall ventilatory load will be reduced. 

Where to start when treating COPD?
Sep 19, 2017

The most important steps to take when managing a COPD patient is first to ensure that the diagnosis is correct and is based on some objective measurement and then to offer appropriate advice about lifestyle issues relevant to the disease, especially smoking cessation and exercise. 

Asthma medication may have psychiatric side effect
Sep 19, 2017

In a Pharmacology Research & Perspectives study, the asthma medication montelukast (trade name Singulair) was linked with neuropsychiatric reactions such as depression and aggression, with nightmares being especially frequent in children.

Age Limit of Pediatrics
Sep 14, 2017

The establishment of arbitrary age limits on pediatric care by health care providers should be discouraged. The decision to continue care with a pediatrician or pediatric medical or surgical subspecialist should be made solely by the patient (and family, when appropriate) and the physician and must take into account the…

Reliability of Examination Findings in Suspected Community-Acquired Pneumonia in Children
Sep 14, 2017

A study found that only 3 examination findings had acceptable diagnostic agreement: wheezing, retractions, and respiratory rate.

Early Probiotic Supplementation does not prevent Eczema and Asthma
Sep 14, 2017

For high-risk infants, early Lactobacillus rhamnosus GG supplementation for the first 6 months of life does not appear to prevent the development of eczema or asthma at 2 years of age

RESPTREC™    Advance your skills. Be a leader. | Twitter Facebook